NetworkNewsBreaks Archive - Page 1813 of 1996

MondayDec 11, 2017 9:03 am

NetworkNewsBreaks – Carl Data Solutions Inc.’s (CSE: CRL) (FSE: 7C5) (OTC: CDTAF) Polish Subsidiary Obtains EU Artificial Intelligence R&D Grant

Carl Data Solutions (CSE: CRL) (FSE: 7C5) (OTC: CDTAF) this morning said that its subsidiary in Poland has received a $300,000 research and development grant through the European Union (“EU”) to fund the exploration and development of artificial intelligence (“AI”) to monitor aging critical infrastructure. The company’s research will primarily focus on machine learning based AI that is able to continuously predict how anticipated storm events will impact water infrastructure, allowing the time needed for workers to protect cities from flooding and other damage. Carl Data Solutions Poland will work closely with the Department of Decision Systems and Robotics at…

FridayDec 08, 2017 12:19 pm

NetworkNewsBreaks – Skinvisible, Inc. (SKVI) Poised for Growth More than Skin Deep

Skinvisible (OTCQB: SKVI) is poised for growth in the booming global topical drug delivery market. A recent article highlights the company’s positioning, stating, “The Nevada-based Company, which develops topical, transdermal and mucosal polymer-based drug delivery systems and formulations that incorporates its patent-pending technology for combining hydrophilic and hydrophobic polymer, is a player in an industry poised to double in size over the next seven years. A new market research report estimates the global topical drug delivery market will grow at a CAGR of 9.2% from USD 101.7 billion in 2016 to reach USD 205.1 billion by 2024. This is good…

FridayDec 08, 2017 12:18 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) DehydraTech™ Shines in Vegas Lights

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) attracted a lot of attention in Las Vegas at this year’s Marijuana Business Conference & Expo due to increased awareness about potential health benefits of cannabinoids and an increased demand for improved CBD-based edibles. A recent article highlights keen interest in Lexaria’s patented DehydraTECH™ delivery technology, stating, “Lexaria’s proprietary technology has been awarded patents in the U.S. and Australia, and it has patents pending in more than 40 other countries. Furthermore, it is the only company in the world to date that has a patent allowed for the oral delivery of all non-psychoactive cannabinoids,…

FridayDec 08, 2017 12:16 pm

NetworkNewsBreaks – RJD Green Inc.’s (RJDG) Healthcare Payment Solution

RJD Green (OTC: RJDG) provides solutions to meet the growing digital needs for industries in various sectors. A recent article highlights an innovative RJDG solution for the health care industry, stating, “RJDG’s IOSOFT Inc. is providing discrete payment applications through software and services being incorporated into health care provider networks, enabling hospitals, individual providers and health care payers to work together more seamlessly. IOSOFT software applications are being integrated by third party administrators and other medical services providers nationally.” To view the full article, visit http://nnw.fm/qL2OP About RJD Green, Inc. The company operates as a holding company with a focus…

FridayDec 08, 2017 12:15 pm

NetworkNewsBreaks – Tapinator, Inc. (TAPM) Tapping into Revenue for Existing Games

Tapinator (OTCQB: TAPM) has implemented a strategy for enhancing engagement and increasing revenue for existing games, which positions the company in the strong global mobile gaming market that Statista.com forecasts will have grown to $188.9 billion by 2020. A recent article highlights Tapinator’s strategy for tapping into this revenue stream, stating, “As reflected in a recent Morningstar article titled, ‘Should You Stuff Your Stocking With Video Game Stocks?’ (http://nnw.fm/0AGSe), TAPM’s strategies for enhancing the engagement of current users and increasing revenue from existing games is right in line with industry leaders and presents a ripe opportunity to increase revenue and…

FridayDec 08, 2017 12:15 pm

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science

Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (OTCQB: PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows researchers to begin their experimentation with the assurance of using biological products that are unmatched in their quality and most likely to produce sound science as a result. An article discussing this reads: "PBIO’s product line is based on a patented, enabling technology platform called pressure cycling technology (PCT), which employs alternating cycles of hydrostatic pressure — ranging between ambient (14.5 psi) and ultra-high…

FridayDec 08, 2017 12:14 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Targets Massive CBD Market Through Eqova Life Sciences Subsidiary

Grey Cloak Tech (OTCQB: GRCK) is positioning itself to profit from the growing cannabinoid (“CBD”) market through its wholly owned subsidiary Eqova Life Sciences. An article discussing this reads: “Eqova Life Sciences recently exhibited the company’s CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company’s formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care…

FridayDec 08, 2017 9:12 am

NetworkNewsBreaks – SeeThruEquity Updates Coverage on PotNetwork Holding, Inc. (POTN)

SeeThruEquity recently issued a company update and price target of $0.40 on shares of PotNetwork Holding, Inc.’s (OTC: POTN) stock. SeeThruEquity increased the price target for PotNetwork based on encouraging results since it initiated coverage of the holding company, such as top line growth and reduction in shares outstanding. New product launches, aggressive marketing initiatives and entry into to new markets were noted by the analyst as upcoming catalysts for the company. To view the full press release, visit http://nnw.fm/rFU2b About PotNetwork Holding, Inc. PotNetwork Holding, Inc. (OTC: POTN) is a publicly traded company that acts as a holding company…

FridayDec 08, 2017 8:30 am

NetworkNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Retains Medical Director to Advise Cannabis Research Programs

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning reported that the company has hired Dr. M. Scott Alexander as a medical director. Alexander’s role will be to confirm the medical integrity of cannabis research programs conducted by the company’s subsidiary, Cannevert Therapeutics Ltd. In addition, Alexander will develop a medical affairs strategy to support cannabis strains currently in development. “Dr. Alexander brings a wealth of medical knowledge, a clear understanding of current clinical practice and regulatory needs, and a pledge to educate all stakeholders about therapeutic strains that are based on Cannevert’s experimental evidence,” Veritas CEO Dr. Lui…

ThursdayDec 07, 2017 2:23 pm

NetworkNewsBreaks – VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Advances IP for Lead Product Candidate with New Methods of Production Patent

Clinical-stage biopharmaceutical company VistaGen Therapeutics (NASDAQ: VTGN) recently announced that it has been issued U.S. Patent No. 9,834,801 by the U.S. Patent and Trademark Office (“USPTO”), strengthening its intellectual property (“IP”) stance. The newly-issued patent covers certain methods of production for AV-101, VistaGen's lead central nervous system (“CNS”) product candidate. "This issued U.S. patent, in conjunction with the potential issuance of additional AV-101 patent applications currently under review worldwide, provides VistaGen with added long-term intellectual property protection for AV-101 and enhances its commercial potential," VistaGen CEO Shawn Singh stated in the news release. To view the full press release, visit…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks